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Abstract
Motivation: It has been proposed that clustering clinical markers, such as blood test results, can be used to stratify patients.
However, the robustness of clusters formed with this approach to data pre-processing and clustering algorithm choices has not
been evaluated, nor has clustering reproducibility. Here, we made use of the NHANES survey to compare clusters generated with
various combinations of pre-processing and clustering algorithms, and tested their reproducibility in two separate samples.
Method: Values of 44 biomarkers and 19 health/life style traits were extracted from the National Health and Nutrition
Examination Survey (NHANES). The 1999–2002 survey was used for training, while data from the 2003–2006 survey was
tested as a validation set. Twelve combinations of pre-processing and clustering algorithms were applied to the training set.
The quality of the resulting clusters was evaluated both by considering their properties and by comparative enrichment
analysis. Cluster assignments were projected to the validation set (using an artificial neural network) and enrichment in
health/life style traits in the resulting clusters was compared to the clusters generated from the original training set.
Results: The clusters obtained with different pre-processing and clustering combinations differed both in terms of cluster
quality measures and in terms of reproducibility of enrichment with health/life style properties. Z-score normalization, for
example, dramatically improved cluster quality and enrichments, as compared to unprocessed data, regardless of the
clustering algorithm used. Clustering diabetes patients revealed a group of patients enriched with retinopathies. This could
indicate that routine laboratory tests can be used to detect patients suffering from complications of diabetes, although
other explanations for this observation should also be considered.
Conclusions: Clustering according to classical clinical biomarkers is a robust process, which may help in patient
stratification. However, optimization of the pre-processing and clustering process may be still required.
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Introduction
Advances in medical informatics, in bioinformatics and in
machine-learning are opening up new venues in biomedical
research. Data is becoming ever more accessible as information
from large populations of patients is now electronically captured,
especially in countries with centralized healthcare. A general move
toward lifelong Electronic Health Records (EHRs), aimed at
integrating available clinical information for an individual, has
been suggested [1,2]. In parallel, the computational tools required
for analyzing complex, biased and error-ridden datasets are
constantly improving.
One possible role for computational analysis of clinical data lays
in improving our ability to understand disease sub-classes, or
stratification. Medical research, as required for use by treating
physicians, often attempts to define disease sub-classes that are
more homogenous in terms of optimal intervention and prognosis.
More refined classifications can, however, help physicians in
achieving ‘personalized medicine’, in which intervention is tailored
to specific patients [3,4]. While great emphasis is currently being
given to identifying biomarkers that will allow adequate stratifica-
tion of patients, it has been shown [5,6] that existing clinical data,
when analyzed with unsupervised learning methods (i.e. clustering),
can be used to uncover classification patterns. According to this
approach, patients are grouped based on a combination of clinical
observations (e.g., laboratory test results, symptoms, complaints,
etc.) and the resulting clusters are tested for enrichment with
patients with similar outcomes or responses to a given treatment.
Claycamp et al. (2001) [6] grouped patients suspected of having
chronic radiation sickness based on blood count values. Using
competitive artificial neural network clustering, they found a cluster
enriched with true chronic radiation sickness patients. Chen et al.
PLoS ONE | www.plosone.org 1 March 2012 | Volume 7 | Issue 3 | e29578extended this idea to develop a ‘clinarray’, in which the entire
spectrum of clinical laboratory tests results was used to cluster
children with similar profiles. Using agglomerative hierarchical
clustering, these authors were able to sub-classify Crohn’s disease
and cystic fibrosis patients in a manner that correlated with the
severity of their disease [5].
While these works demonstrate the potential of utilizing
machine-learning methods commonly used in bioinformatics
(namely, clustering), little is known about the robustness of this
approach. In both studies mentioned, the ability to classify patients
was not repeated with additional datasets, and the sensitivity of the
process to methodological decisions was not assessed.
In this study, we demonstrate the power of unsupervised
learning in clinical data analysis, while evaluating the robustness of
this approach. To achieve these goals, we designed a training-
validation experiment in which the quality of the clusters resulting
from biomarker-based clustering are evaluated in a second dataset.
Two large datasets derived from the National Health and
Nutrition Environmental Study (NHANES; NHANES website.
Available: http://www.cdc.gov/nchs/nhanes.htm Accessed 2011
Dec 4.) were used. The NHANES is a prospective cross-sectional
study in which health state, lifestyle parameters, and a compre-
hensive set of laboratory tests have been recorded for thousands of
random, non-hospitalized USA residents. The quality of clusters
generated with various pre-processing and clustering methods was
compared to evaluate the robustness of a given clustering
approach to methodological decisions. In addition, the robustness
of the clusters to sample choice was evaluated by projecting the
resulting clustering scheme from a training to a validation dataset,
and comparing the enrichment of the resulting clusters from both
datasets with clinical and lifestyle properties. Our results indicate
that the methodology chosen affects the quality of the resulting
clusters, and suggest that clusters are indeed robust across datasets.
We further demonstrate the potential value of clustering to disease
stratification, showing that clustering diabetic patient by their
classical biomarker values reveals biomedically interesting and
non-trivial sub-classes.
Results
To evaluate the robustness of patient clustering by classical
marker values, we derived two datasets (i.e. training and
validation) from the NHANES Study, each comprising data
collected in different years from a random sample of non-
hospitalized individuals. The training dataset was processed with
12 different analysis pipelines (Figure 1), each involving one of
four pre-processing methods and one of three clustering
algorithms. For each pipeline, an artificial neural network (ANN)
was used to cluster the validation set into the same clusters as
defined based on the training set. Enrichment analysis with a set of
known diseases and complaints was then performed on the clusters
both in the training and validation sets, and their consistency was
compared.
2.1 The impact of different pre-processing and clustering
algorithms on the properties of the resulting clusters
Initial comparison of the clusters obtained with the different
clustering pipelines was performed using the HA-SA measure. This
measure reflects the difference in variation between individuals in
different clusters (SA) and individuals in the same cluster (HA), with
high values indicating well defined clusters (i.e. distant and
compact) and low values indicating poorly separated clusters.
Only small differences were observed in the homogeneity of the
clusters obtained with the three different clustering algorithms
(Table 1), when the same pre-processing approach was used.
Clusters generated with Z-score-normalized data, for example,
Figure 1. Methodology overview. A test-validation approach was used to test the impact of methodological choices on the clustering of
individuals according to their classical blood biomedical marker values. The data from the NHANES 1999–2002 surveys was used as a training set,
while the 2003–2006 dataset was used for validation. Various combinations of pre-processing and clustering algorithms were used to define clusters
from the training set (black). For pre-processing (top row), transformation to normal of otherwise non-normal variables, Z-score normalized and Z-
score normalized-with age adjustment using linear regression, were considered (top block). Each resulting dataset was clustered with three different
clustering algorithms (second row): CLICK [18], K-means [21] and self-organizing maps [22]. The resulting clusters were used for enrichment analysis
with health/lifestyle traits and for training an artificial neural network (third row). The artificial neural network was subsequently used to assign
individuals from the validation set to clusters (third row), using the same pre-processing procedure as used to generate the training set clusters
(bottom row). The resulting validation set clusters were also tested for enrichment with the same health/life-style traits as the training set.
Enrichments found in both sets were compared.
doi:10.1371/journal.pone.0029578.g001
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0.46760.06 with the CLICK, K-means and SOM algorithms,
respectively. All of these differences were found to be statistically
significant by Student’s t-test, using p,0.005. A much larger
impact was observed when different pre-processing methods were
used. Z-score normalization dramatically improved the quality of
the clusters. For example, with the CLICK algorithm, a 10-fold
increase was observed in the mean HA-SA value between scaled
and unprocessed data, growing from 0.03560.005 to 0.55460.02
(p,0.001, Student’s t-test; see Table 1).
The effect of age adjustment for this dataset is not as clear. On
the one hand, no striking improvement was observed in cluster
quality, as reflected in their highly similar HA-SA values with or
without age correction (e.g. 0.55460.02 vs. 0.54060.02 using Z-
score normalization with or without age correction, correspond-
ingly, applying the CLICK algorithm in both cases). On the other
hand, the number of clusters identified using the CLICK
algorithm with age-adjusted before-Z-score data was smaller than
the number of clusters identified with Z-score-normalized data
with equivalent HA-SA values. This could reflect some age-based
clustering in the non-adjusted data, where individuals that
otherwise very similar are assigned into different clusters based
on age alone. These results thus suggest that age normalization
may have improved the quality of the clusters identified using the
CLICK algorithm, as it generates fewer clusters without com-
promising cluster homogeneity.
2.2 The robustness of biomarker-based clustering across
datasets
To test whether clusters identified via unsupervised analysis are
robust across datasets, we projected the clusters generated with the
test set to the validation set using an ANN, and compared the
enrichment observed in the clusters from either set in terms of
health/lifestyle properties. We assumed that if the clusters resulting
from grouping individuals based on their biomarker values are
robust to dataset effects, then the resulting clusters should be
similar in terms of their enrichment patterns. To determine
whether this is indeed the case, we first tested whether the clusters
generated from the training dataset can be successfully identified
in the validation set. For most clusters, a cluster with similar
quality could be detected in the validation dataset, as reflected by
their HA-SA values (Table 1). For the CLICK algorithm, for
example, all 24 clusters generated from the training data were
successfully recovered in the validation set. We then tested
whether the clusters produced from the validation dataset had
the same biomedical meaning as did the training set clusters by
comparing their enrichment with health/lifestyle properties of the
individuals included. Nineteen health/lifestyle-related statements
were extracted from the NHANES datasets, choosing traits
pertinent to a sufficiently large subset (n$30; see Table S1b for
complete details). These include mostly diseases (e.g., diabetes,
coronary heart disease, etc.) but also some lifestyle traits (e.g.,
smoking). Three measures were used to evaluate the robustness of
clinical biomarker clustering: (i) The number of valid enrichments,
defined as significant enrichments of the same trait in equivalent
clusters from both training and validation datasets, (ii) the number
of distinct validated enrichments, defined as the number of distinct
terms that were successfully validated and (iii) validated clusters,
defined as the number of clusters in the validation set with one or
more validated enrichments (Table 2). A complete list of all
validated enrichments is provided in Table S3.
Analysis of the enrichment results suggest that use of the SOM
algorithm with Z-score normalization gives the most specific
enrichments. This pipeline produced eight validated clusters (as
compared to four-eight generated by the other pipelines) and an
average fold-enrichment of 7.7 (as compared to 1.9–7 for the other
pipelines). The SOM/Z-score normalization algorithm also had
the highest absolute number of validated enrichments (36, as
compared to 8–33 for the other pipelines). However, this
algorithm did not generate the highest number (or fraction) of
distinct validated enrichments. The SOM/Z-score normalization
algorithm yielded 13 distinct validated enrichments, as compared
to 15 using the CLICK algorithm with the Z-score normalization
pipeline. In fact, detailed analysis of the enrichment obtained with
the different algorithms using scaled data reveals that the CLICK
algorithm finds all the enriched validated terms that are found by
the two other algorithms (Table 3A). In terms of pre-processing,
scaled data yielded the highest number of validated enriched terms
when using the CLICK algorithm (15 compared to 11). However,
the use of age-adjusted pre-processing added one term (‘‘taking
treatment for anemia/past 3 month’’) that was not found with the
scaled data (Table 3B).
2.3. The nature of the resulting clusters
To test whether the observed clusters can define biomedically
homogenous sub-populations, we inspected other cluster charac-
teristics. We hypothesized that if individuals in the same cluster
share similar properties, then the enrichment we observed may
correspond to a specific pattern of biomarker values in that cluster.
To demonstrate that such correspondence can be observed, the
mean biomarker values of three clusters were analyzed in the
Table 1. The quality of clusters obtained with different pre-
processing-clustering pipelines.
Processing pipeline Training Validation
NH A-SA NH A-SA
All Patients CLICK Raw 7 0.035 (0.005) 6 0.05
NormTransf. 861 0.012 (0.003) 6 0.013
Z-Score 2463 0.554 (0.02) 24 0.556
AgeAdj 2163 0.54 (0.02) 17 0.532
K-mns Raw 7 0.022 (0.036) 7 0.031
NormTransf. 861 0.01 (0.0036) 6 0.011
Z-Score 2463 0.644 (0.156) 18 0.522
AgeAdj 2163 0.647 (0.174) 14 0.534
SOM Raw 8 0.026 (0.016) 7 0.032
NormTransf. 861 0.009 (0.003) 6 0.008
Z-Score 20630 0.467 (0.06) 19 0.451
AgeAdj 2063 0.44 (0.076) 17 0.43
Diabetes CLICK Raw 0 - - -
NormTransf. 3 0.033 (0.001) 4 0.033
Z-Score 561 0.64 (0.02) 6 0.622
AgeAdj 561 0.72 (0.04) 6 0.619
For each pre-processing/clustering pipeline, the number of clusters (N) and the
homogeneity-separation difference (HA-SA) are provided. The HA-SA measure
reflects the difference in variation between individuals in different clusters (SA)
and individuals in the same cluster (HA). For the validation set, the mean6SD of
the number of clusters and HA-SA were calculated for 10 re-sampled datasets.
See Materials and Methods for a complete description of the algorithms and
pre-processing methods. K-mns=K-means; NoramTranf=transformation to
normal; Z-score=Z-score normalization; AgeAdj=age adjustment followed by Z-
score normalization. The analysis was performed separately for the NHANES
training and validation sets, using all individuals (‘‘All Patients’’) or restricting
the analysis to diabetic patients (‘‘Diabetes’’).
doi:10.1371/journal.pone.0029578.t001
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Cluster 14 is highly enriched with diabetic individuals. As
expected, members of this cluster are characterized by high levels
of glucose, blood osmolarity and triglycerides, traits that are
indeed hallmarks of unbalanced diabetic patients [7]. Cluster 1 is
enriched with individuals suffering from kidney diseases. Cluster
members are characterized by a high level of creatinine, increased
osmolarity, and low hemoglobin and hematocrit values. While
such traits are found in patients with chronic diseases, they are
highly suggestive of patients with chronic kidney disease, in
particular [8,9]. Cluster 3 is enriched with smokers, and is
characterized by individuals with high hemoglobin, red blood cell
and hematorcrit levels, a pattern characteristic of sufferers of lung
diseases (e.g., smokers and individuals exposed to severely polluted
air [10]). We note that for other clusters, correspondence may be
missed if it involves health/lifestyle traits that were not recorded in
the NHANES dataset, or if careful inspection by an expert in the
appropriate medical field is required to note the correspondence.
2.4. Toward novel classification via biomarker-based
clustering
Some health/lifestyle states were found to be enriched in
multiple clusters (see Table S3). Both clusters 1 and 14, for
example, were enriched with diabetic individuals. These clusters,
however, greatly differ in terms of characteristic patterns (Figure 2).
Mean glucose levels, for example, were very high in cluster 14 but
not in cluster 1 (233695.8 vs. 106635.4 mg/dL, respectively,
p,0.001). This finding, coupled with the iron-related markers,
such as hemoglobin, hematorcrit and iron, that were found to be
relatively low in cluster 1 but not in cluster 14 (13.661.3,
40.463.8 and 78.6628, as compared to 15.161.1, 44.863.2 and
86.1632, p,0.001, p,0.001 and p,0.013 respectively) may
define a group of better-treated diabetics. A similar pattern is
observed for smokers, who are over-represented not only in cluster
3 (as described above) but also in clusters 6, 8 and 12, despite great
differences in their respective patterns. It is possible that the
stratification of smokers reflects some other conditions or
properties of the patients that have a greater impact on biomarker
levels. An intriguing possibility is that the unsupervised approach
reproducibly clusters sub-populations presenting unique clinical
conditions.
To further expand and test this hypothesis, we performed
unsupervised clustering to detect sub-populations of diabetic
individuals. A subset of diabetic individuals (i.e. males, 20 years
of age or more) was extracted from the training and the validation
sets described above (N=299 for the training dataset and N=229
for the validation dataset) by adding two biomarkers that are
routinely tested in diabetes patients, namely BMI (body mass
index) and glycosylated hemoglobin levels (A1C). The resulting
dataset was clustered using the same procedure as described above
(Figure 1) but this time using only the CLICK/Z-normalization
with age adjustment pipeline. This procedure yielded six clusters
involving 245 individuals, with 54 individuals remaining unclas-
sified. To avoid confusion with the clusters discussed above, these
clusters are named D1 through D6. The resulting clusters differ
from each other in terms of their mean patterns (Figure 3). Cluster
Table 2. Comparative enrichment analysis of biomarker-based patient clusters: A quantitative analysis.
Processing pipeline Valid enrichments Validated clusters Enrichment factor
Total Distinct
All Patients CLICK Raw 7/12 4/9 5/5 4.3
NormTransf. 12/16 8/12 4/5 4.3
Z-Score 22/40 15/20 8/13 5.9
AgeAdj 20/38 11/20 8/9 5.3
K-mns Raw 7/11 5/6 5/6 4.5
NormTransf. 11/17 9/14 5/5 4.2
Z-Score 18/37 11/16 7/17 6.4
AgeAdj 11/34 7/15 7/15 7.0
SOM Raw 8/20 4/12 5/7 2.9
NormTransf. 11/13 7/9 5/6 1.9
Z-Score 36/62 13/21 8/16 7.7
AgeAdj 14/28 8/15 8/10 3.8
Diabetes CLICK Raw 0/0 0/0 - -
NormTransf. 0/2 0/2 0 -
Z-Score 2/4 2/3 1/2 -
AgeAdj 4/7 4/6 1/2 1.8
The number of validated terms found to be enriched in clusters generated with the different pre-processing procedures and clustering algorithms tested in this study.
Validated enrichments and validated clusters are defined by the recurrence of statistically significant enrichment in the training and validation datasets. The clusters that
were generated from the test dataset using a particular pre-processing clustering combination were subjected to enrichment analysis with 19 health/lifestyle labels (i.e.
searching for statistically significant over-representation of patients with the trait in each cluster). An artificial neural network, trained with the cluster assignment of
each individual in the training dataset, was used to classify individuals from the validation dataset using the same clinical biomarkers subjected to the same pre-
processing algorithm as was the test dataset. The resulting clustering of the validation set was also subjected to enrichment analysis with the same terms as was the
training set. An enrichment was deemed to be a validated enrichment if the same label was enriched in the test and validation datasets. A validated cluster was defined
as a cluster sharing at least one enriched term between the test and validation sets (i.e. the number of clusters enriched in the training set). The enrichment factor for
each pipeline is the average enrichment factor of the three most significant enrichments. K-mns=K-means; NoramTranf=transformation to normal; Z-score=Z-score
normalization; AgeAdj=age adjustment followed by Z-score normalization.
doi:10.1371/journal.pone.0029578.t002
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glucose levels (with a mean of 111.9635 mg/dL), cluster D1
members are characterized by moderately increased mean glucose
levels (mean of 148.9656 mg/dL), while individuals in cluster D5
have very high glucose levels (mean of 277.46108 mg/dL).
Enrichment analysis relying on health/lifestyle traits described in
the NHANES diabetes questionnaire suggests that the observed
sub-classification of diabetic patients is indeed meaningful. Cluster
D1 was found to be enriched with insulin users and with patients
suffering from common vascular complications of diabetes, namely,
retinopathy (positive answer to the NHANES question ‘‘do you
have other vision troubles due to diabetes’’) and microvascular
complications (e.g., ‘‘vascular and foot ulcer conditions that
required significant time to heal’’). In addition, cluster D1 is
enriched with patients suffering from ‘‘weak or failing kidneys’’.
These enrichments have been successfully reproduced in the
validation dataset. In addition to the validated enrichment, an
intriguing enrichment was observed for cluster D6. This cluster is
enriched with individuals that complain of leg pain while walking
but not other complaints. The validity of this enrichment could not
beassessed,asthiscomplaintwasnotrecordedinthosesurveysfrom
which the validation dataset was derived.
Discussion
Unsupervised classification (i.e. clustering) of individuals based
on routine blood tests has been previously proposed to allow for
the uncovering of patient sub-populations that are seemingly
Table 3. Enrichment analysis of biomarker-based patient clusters: A qualitative view.
Scale
Code Enrichment name CLICK Kmns SOM
Z-score normalization DIQ010 Doctor told you have diabetes Y Y Y
KIQ020 Ever told you had weak/failing kidneys Y Y Y
MCQ160A Doctor ever said you had arthritis Y Y Y
MCQ160B Ever told had congestive heart failure Y Y Y
MCQ160C Ever told you had coronary heart disease Y Y Y
MCQ160E Ever told you had heart attack Y Y Y
MCQ160F Ever told you had a stroke Y Y Y
MCQ160G Ever told you had emphysema Y Y Y
MCQ190 Which type of arthritis Y Y Y
MCQ220 Ever told you had cancer or malignancy Y Y Y
MCQ160D Ever told you had angina/angina pectoris Y Y
MCQ140 Trouble seeing even with glass/contacts Y Y
MCQ160L Ever told you had any liver condition Y Y
SMQ040 Do you now smoke cigarettes Y Y
MCQ170L Do you still have a liver condition Y
Code Enrichment name Raw Norm Z-Scal. AgeAdj
CLICK Clustering DIQ010 Doctor told you have diabetes Y Y Y Y
KIQ020 Ever told you had weak/failing kidneys Y Y Y Y
MCQ140 Trouble seeing even with glass/contacts Y Y Y
MCQ160A Doctor ever said you had arthritis Y Y Y Y
MCQ160B Ever told had congestive heart failure Y Y Y Y
MCQ160C Ever told you had coronary heart disease Y Y Y
MCQ160D Ever told you had angina/angina pectoris Y
MCQ160E Ever told you had heart attack Y Y Y
MCQ160F Ever told you had a stroke Y
MCQ160G Ever told you had emphysema Y
MCQ160L Ever told you had any liver condition Y Y
MCQ170L Do you still have a liver condition Y Y
MCQ190 Which type of arthritis=1 (Rheum. Arth.) Y
MCQ220 Ever told you had cancer or malignancy Y
SMQ040 Do you now smoke cigarettes Y Y Y
MCQ053 Taking treatment for anemia/past 3 mos Y
The NHANES code and description of validated terms found in clusters generated by pre-processing with the Z-score normalization method and clustering algorithm
with three algorithms (CLICK, K-means and SOM) (top) or using the CLICK clustering algorithm with four pre-processing procedures (bottom). Raw=no transformation;
Norm=transformation to normal; Z-score normalization or Z-score normalization with age-adjustment). All the marked terms were enriched significantly (hyper
geometric test, P value,0.05) in both the training and validation sets.
doi:10.1371/journal.pone.0029578.t003
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study, we have demonstrated, for the first time, which clusters
resulting from this type of analysis are reproducible across cohorts.
Such robustness is essential to allowing clustering to serve as the
basis for novel sub-classifying methods. We have demonstrated
that a classification scheme developed in one dataset can be used
for classifying a new dataset, and that the resulting clusters in the
new dataset are most enriched in terms of the same clinical and
lifestyle traits.
In addition to exploring the robustness of the clustering approach
in clinical applications, we further demonstrated the potential of
unsupervised learning to uncover non-trivial sub-classes. As some
conditions were found to be enriched in more than one cluster, we
believe that a more accurate stratification within a given disease
may be achieved with this approach. For example, routine lab tests
defined a sub-cluster of diabetic patients enriched with patients
complainingof leg painswhile walking,a commonearly indicatorof
peripheral artery disease (PAD). PAD is a frequent complication of
diabetes involving peripheral arterial dysfunction and is associated
with an elevated risk of cardiovascular events, amputations, and a
general decline in a patient’s quality of life. The early diagnosis and
treatment of PAD inpatients with diabetes may have significant and
profound clinical implications [11]. Our results may provide an
early indication that PAD can be diagnosed from routine blood
tests, although this has yet to be validated with an independent
dataset. However, patients suffering from pains are more likely to
Figure 2. Selected clusters from the NHANES training set. (A) The mean and standard deviation of biomarker values are shown for three
selected clusters generated with 4152 males 20 years of age or older from the NHANES training set, using the Z-score normalized/CLICK pre-
processing/clustering combination. For each cluster, the total number of individuals (top, right) and selected health/lifestyle traits that are
significantly enriched in that cluster (top, left) are provided. For each enriched term, the enrichment factor (i.e. the frequency of the term in a cluster
divided by its frequency in the entire dataset) is also provided. (B) Comparison of the original values of selected biomarkers in clusters 1, 3 and 14. The
values for Hb are enlarged in the top middle section of the figure.
doi:10.1371/journal.pone.0029578.g002
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some clinical biomarkers (e.g., hemoglobin [12]). Moreover, leg
pains, as well other muscle pains, may be a side effect of the use of
statins [13]. Thus, the clinical value of such results should be best
investigated using data from longitudinal studies, after omitting
statins. Using the artificial neural network described above, diabetic
patients belonging to the same cluster can be identified. If the
pattern of blood test values is indeed predictive of PAD, this pattern
should precede the use of analgesics or complaints about leg pains.
Unfortunately, the datasets we have used throughout this study are
cross-sectional, and do not separate the disease from various
treatments. Another possible advantage of using longitudinal data is
the availability of multiple observations from the same individual.
This allows temporal patterns to be considered. Temporal patterns
have been successfully used in supervised machine-learning with
clinical data [14]. Our results, however, indicate that it may be also
useful to study temporal patterns in clinical data using unsupervised
learning. Unsupervised learning allows suggesting new stratification
schemes, rather than learning how to classify patients according to
known strata. We would thus propose that adding temporal analysis
into unsupervised learning may help detect new patient stratifica-
tion schemes.
Our results indicate that age adjustment has an inconsistent
effect on clusters quality. On the one hand, clustering the entire
population with age-correction decreased the number of clusters
without degrading their compactness (i.e. ,5% effect on HA-SA),
yet also decreased the number of distinct valid enrichments by
25% or more. On the other hand, in the diabetic population, age-
correction doubled the number of distinct valid enrichments (from
2 to 4) without changing the number of clusters and with little
impact on clusters compactness (i.e. ,5% change in HA-SA values).
This suggests that the clusters obtained with age-corrected marker
values are more biologically uniform for diabetic patients and less
uniform for the general population. These inconsistencies can be
explained, at least in part, by complex and non-linear interactions
between age and marker levels [15,16], which can interfere with
the relatively simple linear correction method we have used in this
study. In fact, we have shown that age effects are more linear in
advanced ages (.50), making linear age correction more
appropriate in generally older diabetic patients. Age may also
have indirect affects on marker levels via its association with
various diseases, co-morbidities and non-pathological conditions
that, in turn, effect marker levels. Further research is required to
better understand how and when age effects need to be corrected
for. Toward this goal, we have recently described a database for
recording age-disease interactions from biomedical publications
[17]. With this resource and others, more refined models for age
correction could be developed that will further enhance the power
of unsupervised learning in clinical data.
Another aspect of this work is the applicability of Expander, a
tool specifically designed for microarray analysis [18], to clinical
data analysis. It has been previously suggested that the
methodology used to analyze large, multi-dimensional datasets in
biological settings (e.g., transcription profiles) is perfectly suited to
the processing of clinical biomarkers data [10]. However, the
suitability of such tools for this task had not been directly
evaluated, and the effect of the parameter choice (e.g., clustering
algorithm) was not evaluated. Using a standard microarray
analysis tool with only minor adjustments to the pre-processing
pipeline, we were able to cluster thousands of individuals, to
visualize the results and to test the resulting clusters for
enrichment. This means that the arsenal of computational tools
available for analysis of biological data, which are characterized by
high noise tolerance and performance suitable for large datasets,
can be used for medical data analysis.
Studying large databases from medical records using bioinfor-
matics tools carries the hope of revitalizing efforts already in place
to implement a more personalized form of medicine. In all
likelihood, it will take some time before genetic, proteomics and
other novel markers that are being developed for this purpose
reach the cutting edge of medical practice. With the findings
reported here, we have demonstrated that some of the goals of
personalized medicine may have already been met using classical
clinical biomarkers. In the past, analysis of these classical markers
was limited to the methods of available linear and additive models.
Moving toward novel methodologies that make use of non-linear
and non-additive models to uncover cryptic sub-populations may
help identify groups of patients that are more likely to respond
optimally to a more tailored treatment. Bioinformatics tools are
most suitable for such analyses, as they incorporate computational
analysis methods specifically chosen for their ability to handle
noisy, error-ridden and often biased data.
Basic biological research might also benefit from the knowledge
generated by patient clustering based on clinical biomarkers. The
study of processes such as aging, for example, could benefit from
such analysis [15]. As one of the best sources of data for studying
inter-individual variation, clinical data offer the possibility to study
hundreds of phenotypic biomarkers recorded from many individ-
uals. The clusters we have described here can be used to dissect the
sources of variation in clinical markers, pointing to common
causes that result in similar differences in multiple individuals.
We believe that further research is required to explore the
approach introduced here, to optimize the process for clinical and
biological research applications, and to investigate its potential for
significant discoveries in clinical and biological research. The
results obtained suggest that this novel methodology may provide
biomedical researchers with insight not previously available.
Materials and Methods
Data sources
Data from the National Health and Nutrition Examination
Survey (NHANES), including the 1999–2002 datasets (the
‘training dataset’) and the 2003–2006 datasets (the ‘validation
dataset’), were used in this study. Biomarker values were extracted
from the relevant files in both sets, omitting markers not routinely
tested in clinical settings (e.g., serum vitamin C levels). To avoid
the gender differences that occur in many biomarkers and the non-
linear and complex changes associated with childhood [15], only
males 20 years of age or older were considered. After omitting
redundant variables (i.e. the same measurement provided with
different units), a matrix with 44 variables (Table S1a) over 4151
or 4225 individuals was extracted for the training and validation
datasets, correspondingly.
Figure 3. Selected clusters from the NHANES diabetic subset. (A) The mean and standard deviation of biomarker values are shown for four
selected clusters generated with 299 males 20 years of age or older from the NHANES training set with self-reported type 2 diabetes mellitus.
Clustering was performed using the Z-score normalized with age adjustment/CLICK pre-processing/clustering combination. For each cluster, the total
number of individuals (top, right) and selected health/lifestyle traits that are significantly enriched in that cluster (top, left) are provided. For each
enriched term, the enrichment factor (i.e. the frequency of the term in a cluster divided by its frequency in the entire dataset) is also provided. (B)
Comparison of the glucose levels in clusters 1, 2, 5 and 6.
doi:10.1371/journal.pone.0029578.g003
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Three derived datasets were generated from the raw data,
applying increasingly rigorous pre-processing by aggregating the
following procedures: (a) Normal transform of markers with non-
normal distribution of values (see Table S1a). Normality was
estimated using the Skewness value for each blood marker,
Skewness values between 21 to 1 indicated normal distribution
[19], (b) scaling each marker to the standard normal distribution,
the so-called Z-score transformation, as implemented in R [20],
and (c) applying linear-regression-based age correction for those
variables found to significantly correlate with age (using the
Pearson correlation coefficient, p,0.05 and r.60.1), as illustrat-
ed in Figure 4 and described in full in Table S2.
Clustering and enrichment analysis
The K-means, SOM and CLICK algorithms, as implemented
in Expander (version 4.1), were used for clustering [18]. First, the
CLICK algorithm was used since it requires no prior knowledge of
the number of expected clusters. To facilitate the comparison
between clustering algorithms, the number of clusters detected by
CLICK was used as the expected number of clusters for K-means
clustering and as the total number of array cells in SOM. To
compare the performance of algorithms and pre-processing
methods, the mean and SD of the HA-SA measure were calculated
using a re-sampling approach (removing 3% of the data for each
run, N=10). The statistical significance of differences in HA-SA
values was estimated using Student’s t- test. Enrichment analysis
was conducted using the General Enrichment Analysis option of
Expander.
Machine-learning
A neural network model was trained on the cluster assignment
of individuals from the training set, and was used to assign
individuals from the validation set into clusters. Implementation of
Figure 4. The correlation between selected blood markers and age. Linear regression was calculated for all biomarkers, and least square
regression lines (red) were fitted for each marker. r – Pearson correlation coefficient, P – p value, CI- confidence interval of the p-value. (A) Raw data
from the training set; (B) training set data after age adjustment. (C) diabetic males, raw data from the training set.
doi:10.1371/journal.pone.0029578.g004
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SPSS Inc., Chicago, IL, USA) was conducted, with the exhaustive
prune option selected.
Supporting Information
Table S1 Descriptive statistics. (A) Details of the biomarkers
used in this study. Several statistical properties of each biomarker
are provided, including the number of observations (N), minimal
(min) maximal (max) and mean (mean) values, as well as the
standard deviation (Std Dev).
LBiomarker is natural-log trans-
formed in the appropriate pre-processing/clustering pipeline;
ABiomarker is linearly adjusted for age in the appropriate pre-
processing/clustering. (B) The statistical properties of Health/life
style variables used for enrichment analysis. For each variable, the
code, a short description and the number of subjects that answered
positively are recorded for both the training and the validation
sets.
(XLS)
Table S2 Details of the age adjustment process. For each
variable, the correlation coefficient and the parameters used for
age adjustment parameters are provided. Age adjustment is
performed using the equation V9=V2(a*age+b)+m where V9 is the
adjusted value, V is the raw value and a, b and m are the
adjustment parameters.
(XLS)
Table S3 Complete results of the enrichment analysis.
Details of the enrichment analysis results for all health/life style
variables in the training and validation sets. Results are presented
with four methods of pre-processing and 3 clustering algorithms.
For each analysis pipeline, results are presented for the training set
(‘‘1999–2002’’) and for the validation set (‘‘2003–2006’’). For each
trait, information about the cluster (cluster number, size and the
number of individuals with the trait that are in the cluster) are
provided as well as information about the trait (NHANES code,
the actual question that was asked and the total number of
individuals who responded positively to the questions in the
dataset) and information about the enrichment (p-value and
enrichment factor). Enrichment is calculated as the frequency of
the term in a cluster divided by its frequency in the entire dataset.
(XLS)
Acknowledgments
We would like to thank Prof. Ron Pinter and Prof. Eytan Ruppin for
fruitful discussion of the ideas presented in this paper.
Author Contributions
Conceived and designed the experiments: MG AM ER. Performed the
experiments: MG. Analyzed the data: MG ER. Contributed reagents/
materials/analysis tools: MG. Wrote the paper: MG AM ER.
References
1. Simon SR, Kaushal R, Cleary PD, Jenter CA, Volk LA, et al. (2007) Physicians
and electronic health records: a statewide survey. Arch Intern Med 167:
507–512.
2. Wilson JF (2007) Lessons for health care could be found abroad. Ann Intern
Med 146: 473–476.
3. Dietel M, Sers C (2006) Personalized medicine and development of targeted
therapies: The upcoming challenge for diagnostic molecular pathology. A
review. Virchows Arch 448: 744–755.
4. Weston AD, Hood L (2004) Systems biology, proteomics, and the future of
health care: toward predictive, preventative, and personalized medicine.
J Proteome Res 3: 179–196.
5. Chen DP, Weber SC, Constantinou PS, Ferris TA, Lowe HJ, et al. (2007)
Clinical arrays of laboratory measures, or ‘‘clinarrays’’, built from an electronic
health record enable disease subtyping by severity. AMIA Annu Symp Proc. pp
115–119.
6. Claycamp HG, Sussman NB, Okladnikova ND, Azizova TV, Pesternikova VS,
et al. (2001) Classification of chronic radiation sickness cases using neural
networks and classification trees. Health Phys 81: 522–529.
7. Lewis B, Mancini M, Mattock M, Chait A, Fraser TR (1972) Plasma triglyceride
and fatty acid metabolism in diabetes mellitus. Eur J Clin Invest 2: 445–453.
8. Levey AS, Coresh J, Balk E, Kausz AT, Levin A, et al. (2003) National Kidney
Foundation practice guidelines for chronic kidney disease: evaluation,
classification, and stratification. Ann Intern Med 139: 137–147.
9. Weiss G, Goodnough LT (2005) Anemia of chronic disease. N Engl J Med 352:
1011–1023.
10. Smith J, Protti D (2005) Bioinformatics meets clinical informatics. Stud Health
Technol Inform 116: 27–32.
11. Marso SP, Hiatt WR (2006) Peripheral arterial disease in patients with diabetes.
J Am Coll Cardiol 47: 921–929.
12. Johnson ST, Fueger JT, Gottschall JL (2007) One center’s experience: the
serology and drugs associated with drug-induced immune hemolytic anemia–a
new paradigm. Transfusion 47: 697–702.
13. Wierzbicki AS, Poston R, Ferro A (2003) The lipid and non-lipid effects of
statins. Pharmacol Ther 99: 95–112.
14. Shahar Y, Musen MA (1996) Knowledge-based temporal abstraction in clinical
domains. Artif Intell Med 8: 267–298.
15. Fliss A, Ragolsky M, Rubin E (2008) Reverse translational bioinformatics: a
bioinformatics assay of age, gender and clinical biomarkers. AMIA summit on
translation bioinformatics: San Francisco, CA.
16. Rubin E, Gordon M, Sergienko R, Ragolsky M, Lunenfeld E, et al. (2011)
Ethnic differences in age-related changes of postpartum hemoglobin levels. Arch
Gynecol Obstet 283(2): 173–8.
17. Geifman N, Rubin E (2011) Towards an Age-Phenome Knowledge-base. BMC
Bioinformatics 12: 229.
18. Sharan R, Maron-Katz A, Shamir R (2003) CLICK and EXPANDER: A
system for clustering and visualizing gene expression data. Bioinformatics 19:
1787–1799.
19. Groeneveld R, Meeden G (1984) Measuring Skewness and Kurtosis. The
Statistician 33: 391–399.
20. Fisher RA (1915) Frequency distribution of the values of the correlation
coefficient in samples of an indefinitely large population. Biometrika (Biometrika
Trust) 10: 507–521.
21. Hartigan JA (1975) Clustering Algorithms. New York: Wiley.
22. Tamayo P, Slonim D, Mesirov J, Zhu Q, Kitareewan S, et al. (1999)
Interpreting patterns of gene expression with self-organizing maps: methods and
application to hematopoietic differentiation. Proc Natl Acad Sci U S A 96:
2907–2912.
Patient Clustering from Classical Markers
PLoS ONE | www.plosone.org 10 March 2012 | Volume 7 | Issue 3 | e29578